ClinicalTrials.gg
Sign In

Radiodermatitis clinical trials

The registry lists 127 studies for Radiodermatitis across more than 10 countries. 26 are recruiting or about to start. 88 of them are mainly about Radiodermatitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.

Get an email when these change. Save the Radiodermatitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
59
Recruiting
19
Status unknown
18
Terminated
10
Withdrawn
9
Not yet recruiting
5

Phase

Phase 2
27
Phase 3
18
Phase 1
13
Early Phase 1
3
Phase 4
2

Where

United States
31
China
16
Brazil
10
France
9
Canada
9
Israel
7

Who runs them

West China Hospital (9) · Sunnybrook Health Sciences Centre (7) · ProCertus BioPharm, Inc (3) · University of Brasilia (3) · Wake Forest University Health Sciences (3) · Mayo Clinic (3) · Stratpharma AG (3) · Instituto Nacional de Cancer, Brazil (3)

What is being tested here

Drugs under test in Radiodermatitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Adapalene101
Indian frankincense101
Diclofenac Sodium Gel101
Thioctic Acid101
Norepinephrine003
Sodium Hypochlorite012
Hypochlorous Acid012
Urea012
Sapropterin002
Mometasone Furoate002

Drug classes tested here Corticosteroids 3

Coming up

4phase 3 studies under way
10studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10, phase 3 first

Who these studies take

Of the 19 Radiodermatitis studies recruiting now, 6 (32%) set no upper age limit and 5 (26%) stop at 75 or younger. 1 (5%) take children under 18. 5 (26%) are for women only and 0 (0%) for men only; 1 (5%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
101 (5%)0 (0%)
1817 (89%)13 (68%)
3018 (95%)14 (74%)
4019 (100%)14 (74%)
5019 (100%)14 (74%)
6518 (95%)14 (74%)
7516 (84%)14 (74%)
857 (37%)6 (32%)

Across all 127 studies, recruiting or not: 16% stop at 75 or younger and 4% at 65; 7% take children; 43% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Radiodermatitis studies take

Of 39 interventional studies with no phase under Radiodermatitis, half reached primary completion within 17 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase17 mo11–54 · 39 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 12, 2026.

Started recruiting1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 127. Browse all 127 → or search them.